Delivery Order SPE2DB20D3101-SPE2DB25FRRF2
- Not listed
- This is a $1,614.43 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of BRILINTA 90 MG TABLET 60S, a pharmaceutical product. The award has an ultimate completion date of August 19, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of prescription medications, over-the-counter drugs, and medical supplies to support various government...
- The Defense Logistics Agency awarded a delivery order valued at $1,248.39 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of BRILINTA 60 mg tablets. The firm-fixed-price contract, valued at $13,837.86, has an ultimate completion date of July 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a wide range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,157.10 contract is for the delivery of BRILINTA 90 MG TABLET 60S, a prescription medication. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,418.96 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the procurement of 4,566,162,380 units of the medication BRILINTA 90 MG TABLET 60S. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) with a contract value of $1,780.51. This competitively awarded, firm fixed price delivery order is set to be completed by July 28, 2025, and represents performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation and is issued as a child order under...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,816.41 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,567,116,884 units of the drug BRILINTA 60 MG TABLET 60S. The contract has a period of performance through February 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to supply a comprehensive...
- This is a $1,206.63 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of BRILINTA 60 MG TABLET 60S. The contract is a Firm Fixed Price contract with a period of performance through July 23, 2024. Amerisourcebergen is a major pharmaceutical distributor that supplies a wide range of prescription medications, over-the-counter drugs, and medical supplies to support various government agencies and healthcare programs, including the military....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRILINTA 90 MG TABLET 60S. The contract has an ultimate completion date of April 24, 2025 and a ceiling value of $2,687.32. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,037.22 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4566964604 BRILINTA 60 MG TABLET 60S, a cardiovascular medication, with a period of performance through January 17, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRRF2Delivery Order
The Defense Logistics Agency awarded a $1,364.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of BRILINTA 60 mg tablets (60 count). The contract, with an ultimate completion date of July 30, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through competitive procurement without a set-aside designation. The company's federal contract portfolio demonstrates extensive experience supplying brand-name and generic medications to support Defense Health Agency and military healthcare systems. This award falls within DLA's medical supply chain operations, which leverage AmerisourceBergen's capabilities to deliver critical pharmaceutical products across multiple therapeutic domains to support federal medical procurement needs for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/29/25 |